Original Publication Date: 1 May, 2015
Publication / Source: Future Oncology
Authors: Sarah F Adams & Fabian Benencia
Epithelial ovarian cancer affects approximately one in 70 women and is characterized by presentation at late stages resulting in poor survival outcomes, with only 45% of women surviving 5 years after diagnosis . Standard treatment of ovarian cancer includes surgery and cytotoxic chemotherapy. Unfortunately, although up to 80% of women achieve clinical remission with this regimen, the majority will experience relapsed disease, the development of chemotherapy resistance, and death due to cancer-associated morbidity .